Rhythm Pharmaceuticals, Inc. financial data

Symbol
RYTM on Nasdaq
Industry
Pharmaceutical Preparations
Location
222 Berkeley Street, 12 Th Floor, Boston, MA
State of incorporation
Delaware
Fiscal year end
December 31
Former names
RHYTHM METABOLIC, INC. (to 8/12/2015)
Latest financial report
10-Q - Q2 2024 - Aug 6, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 574 % -28.1%
Quick Ratio 17.2 %
Debt-to-equity 154 % +203%
Return On Equity -222 % -188%
Return On Assets -78.2 % -53.1%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 61.1M shares +7.44%
Common Stock, Shares, Outstanding 61.1M shares +7.38%
Entity Public Float 887M USD +371%
Common Stock, Value, Issued 60K USD +5.26%
Weighted Average Number of Shares Outstanding, Basic 61M shares +7.29%
Weighted Average Number of Shares Outstanding, Diluted 61M shares +7.29%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 222M USD +91.4%
Costs and Expenses 367M USD +63.8%
Operating Income (Loss) -266M USD -47.1%
Nonoperating Income (Expense) 7.5M USD
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -258M USD +31.9%
Income Tax Expense (Benefit) 479K USD
Net Income (Loss) Attributable to Parent -259M USD -42.4%
Earnings Per Share, Basic -4.36 USD/shares -33.3%
Earnings Per Share, Diluted -0.55 USD/shares +32.9%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 162M USD +39.8%
Cash, Cash Equivalents, and Short-term Investments 319M USD +25.8%
Accounts Receivable, after Allowance for Credit Loss, Current 17.6M USD +27.2%
Inventory, Net 12M USD +94.1%
Other Assets, Current 6.67M USD -10%
Assets, Current 357M USD +25.9%
Other Long-term Investments 12.8M USD -17.8%
Property, Plant and Equipment, Net 973K USD -45.1%
Operating Lease, Right-of-Use Asset 3.7M USD +273%
Other Assets, Noncurrent 15M USD -9.94%
Assets 382M USD +23.2%
Accounts Payable, Current 4.54M USD -45.8%
Accrued Liabilities, Current 48.1M USD +34.6%
Liabilities, Current 54.7M USD +18.7%
Operating Lease, Liability, Noncurrent 3.3M USD +272%
Other Liabilities, Noncurrent 35.6M USD
Liabilities 202M USD +58.5%
Accumulated Other Comprehensive Income (Loss), Net of Tax -617K USD -4307%
Retained Earnings (Accumulated Deficit) -1.07B USD -32.1%
Stockholders' Equity Attributable to Parent 39.3M USD -78.4%
Liabilities and Equity 382M USD +23.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -40.7M USD -11.8%
Net Cash Provided by (Used in) Financing Activities 4.24M USD
Net Cash Provided by (Used in) Investing Activities 30.1M USD +62.7%
Common Stock, Shares Authorized 120M shares 0%
Common Stock, Shares, Issued 61.1M shares +7.38%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -6.52M USD +63.8%
Deferred Tax Assets, Valuation Allowance 267M USD +23%
Deferred Tax Assets, Gross 267M USD +22.9%
Operating Lease, Liability 4.12M USD +155%
Payments to Acquire Property, Plant, and Equipment 47K USD -63%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -261M USD -44.1%
Lessee, Operating Lease, Liability, to be Paid 6.12M USD +245%
Property, Plant and Equipment, Gross 5.4M USD +0.9%
Operating Lease, Liability, Current 816K USD +12.4%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.1M USD +120%
Lessee, Operating Lease, Liability, to be Paid, Year One 456K USD -46.4%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 2.01M USD +1154%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.13M USD
Deferred Tax Assets, Operating Loss Carryforwards 154M USD +13.4%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.15M USD
Additional Paid in Capital 1.11B USD +11.8%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 858K USD +64.6%
Deferred Tax Assets, Net of Valuation Allowance 338K USD -6.37%
Interest Expense 15.6M USD +55.3%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%